Contact Us
Company Overview
|
Pipeline / Clinical Trials
|
Science & Discovery
|
Business Development
|
Investors
Overview
|
Stock Data
|
Governance
|
SEC Filings
|
News & Events
|
Presentations
|
Fundamentals
|
Information Request
Press Release Archive
Press Release Archive
2010 >
2009
>
2008
>
2007
>
2006
>
2005
>
2004
>
2003
>
2002
>
2001
September 2, 2010
RegeneRx Appoints R. Don Elsey to Board of Directors
August 2, 2010
British Researchers Report that Tβ4 is Essential to Heart Development
July 19, 2010
Researchers Report in Neuroscience that Tβ4 Improves Neurological Function after Stroke
July 8, 2010
RegeneRx Awarded Australian Patent for New Tβ4 Applications
June 2, 2010
RegeneRx Announces Exercise of Over-Allotment Option for Recent Public Offering
May 25, 2010
Annals of the New York Academy of Sciences Publishes Thymosin Beta 4 Research Papers
May 24, 2010
Researchers Report Thymosin Beta 4 Significantly Reduces Damage from Traumatic Brain Injury and Improves Brain Function in Experimental Animals
May 18, 2010
RegeneRx Announces Pricing of Public Offering
May 14, 2010
First Human Data on RegeneRx's Drug Candidate RGN-259 Published in Archives of Ophthalmology
May 13, 2010
RegeneRx Awarded $3 Million Grant from National Institutes of Health for Development of Heart Attack Drug
April 16, 2010
RegeneRx Biopharmaceuticals Announces Proposed Public Offering
April 8, 2010
New Tβ4 Eye Data to be Presented at ARVO Meeting
April 1, 2010
RegeneRx Announces Going Concern Qualification
March 5, 2010
Researchers Report that Thymosin beta 4 Improves Neurological Function after Stroke
March 2, 2010
RegeneRx Biopharmaceuticals' President and CEO to Present at 22nd Annual Roth Capital Growth Stock Conference
February 26, 2010
Researchers Report Novel Biological Properties of Fragments of Thymosin Beta 4
February 8, 2010
Researchers Report Elevated Levels of Tβ4 Levels Predict Patient Survival in Hepatitis B Virus-related Liver Failure
February 5, 2010
Researchers Report that Tβ4 Increases Skeletal Muscle and May Have a Role in the Treatment of Duchenne Muscular Dystrophy
January 21, 2010
RegeneRx Biopharmaceuticals, Inc. Moving to New Corporate Office Space
January 12, 2010
NIH Awards Over $5,000,000 for Tβ4 Research in 2009/2010
home
|
Contact Us
|
Resources
|
Site Map
|
Search
